+499.5%
MRNA vs TRGP
+80.7%
+418.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TRGP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.2% | -1.0% | -2.7% |
| 7D | +5.5% | +0.8% | +4.7% | +5.8% |
| 30D | +158.7% | +11.5% | +147.2% | +164.2% |
| 3M | +182.1% | +9.0% | +173.1% | +187.4% |
| 6M | +151.8% | +20.5% | +131.3% | +152.9% |
| YTD | +393.6% | +59.5% | +334.0% | +359.5% |
| 1Y | +499.5% | +77.9% | +421.6% | +455.2% |
| All | +499.5% | +80.7% | +418.8% | +455.2% |
Cumulative growth
Daily Returns
Daily percentage return beside TRGP.
Daily Out/Under-Performance
Portfolio return minus TRGP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TRGP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TRGP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling